HealthEquity (NASDAQ:HQY) Earns “Outperform” Rating from Barrington Research

HealthEquity (NASDAQ:HQY)‘s stock had its “outperform” rating reiterated by stock analysts at Barrington Research in a research note issued to investors on Friday,Benzinga reports. They presently have a $112.00 target price on the stock. Barrington Research’s price objective points to a potential upside of 14.98% from the company’s current price.

A number of other equities analysts have also weighed in on HQY. Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price for the company. Raymond James upped their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Finally, Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and an average price target of $112.92.

HealthEquity Price Performance

HQY opened at $97.41 on Friday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The company has a fifty day simple moving average of $105.68 and a 200 day simple moving average of $95.21. The stock has a market cap of $8.44 billion, a P/E ratio of 89.37, a P/E/G ratio of 1.60 and a beta of 0.62.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HealthEquity

Hedge funds have recently bought and sold shares of the company. Ameritas Investment Partners Inc. raised its holdings in HealthEquity by 0.3% in the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company’s stock valued at $3,248,000 after acquiring an additional 88 shares during the period. Smartleaf Asset Management LLC raised its holdings in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares during the period. Louisiana State Employees Retirement System raised its holdings in HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund raised its holdings in HealthEquity by 0.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock valued at $1,706,000 after acquiring an additional 100 shares during the period. Finally, State of Michigan Retirement System raised its holdings in HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock valued at $1,988,000 after acquiring an additional 100 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.